Our IDEA-FAST webinar on “New Ways of Measuring Fatigue and Sleep Disturbances in Chronic Diseases” witnessed active participation from a diverse group of attendees, including
Clinical staff members play a pivotal role in the delivery of the ongoing Clinical Observational Study. Their expertise and dedication are essential for the successful
We are excited to announce the upcoming webinar by IDEA-FAST, which will be held on 7 June 2023 from 2:00 to 4:00 PM CET. This
In the second spotlight we talk to Dr. Jennifer Kudelka. She is a medical doctor at the Department of Neurology of the University Hospital in
Dr. Jan Dixon, physician and researcher at the Royal Victoria Infirmary, Newcastle, is the new Associate Principal Investigator of UNEW in the IDEA-FAST project. 1.
We are launching a new segment to present the work of Early Career Researchers in IDEA-FAST. In this first instalment, we talk to Chloe Hinchliffe, a
Our newly published research presents results on using wearable sensing technology to assess fatigue and sleep in patients with chronic diseases. The article provides clinicians
One of the main goals of the IDEA-FAST project is to identify novel digital measures for fatigue and sleep disturbances. To achieve this goal, a
“Being up with the lark”, “the early bird catches the worm”, or “being a night owl” – these phrases are all familiar. A work-focused and digitally connected culture produces the
My family and I moved from southern Germany to northern Germany four years ago. It is beautiful here. However, there is something that I perceive
There is no doubt that the global pandemic caused by COVID-19 has impacted all sectors of society and the whole population, especially citizens affected by
The aim of the feasibility study, which started in July this year, is to gather information on a variety of potential digital measures captured with
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
